On January 3, 2018 BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) reported that executives from the Company are scheduled to provide a corporate summary and update regarding the Company’s clinical programs at the 36th annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2018 at 3:30 p.m. Pacific Time (Press release, BioCryst Pharmaceuticalsa, JAN 3, 2018, View Source [SID1234522831]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Links to a live audio webcast and replay of the presentation may be accessed on the BioCryst website events page at View Source